Hangzhou, China

Donghui Yang

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Adlai Nortye Biopharma Co., Ltd.. Active years: 2021-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Donghui Yang. Retrieved from https://idiyas.com/inventor/donghui-yang-f3jbd5hr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 4.5

ph-index = 1


Company Filing History:


Years Active: 2021-2024

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Mind of Donghui Yang

Introduction

Donghui Yang is a notable inventor based in Hangzhou, China. He has made significant contributions to the field of biopharmaceuticals, holding three patents that reflect his innovative approach to tumor immunotherapy and antibody display technologies. His work enhances the understanding and efficacy of treatments, aligning well with advancements in medical science.

Latest Patents

Donghui Yang's latest patents include two groundbreaking innovations:

1. **System and Method for Screening and Assessing Agents for Tumor Immunotherapy** - This innovative system relates to a comprehensive method for effectively screening agents intended for tumor immunotherapy. The patent outlines how it assesses the effects on target cells, non-target cells, and tumor infiltration. The ability to systematically gauge agent effectiveness and safety against tumor immune cells marks a significant advancement in cancer treatment methodologies.

2. **Construction of Fully Human Antibody Yeast Display Technique** - This patent details a novel construction method for a yeast display library (YSD). Yang's technique involves a construct for the yeast display library, an expression vector, and a host cell, all contributing to a high transformation efficiency and rich diversity in antibody production.

Career Highlights

Donghui Yang is currently associated with Adlai Nortye Biopharma Co., Ltd., a company that focuses on developing innovative therapies for the treatment of cancer. Through his role, Yang has been instrumental in pushing the boundaries of biopharmaceutical research, particularly in tumor immunotherapy. His dedication to enhancing patient outcomes is evident in his patent contributions.

Collaborations

Throughout his career, Donghui Yang has collaborated with talented professionals, including coworkers Yang Lu and Nanhai He. These collaborations are pivotal in fostering an environment of innovation, allowing for the sharing of ideas and expertise, ultimately propelling advancements in their field.

Conclusion

Donghui Yang stands out as a prominent inventor whose work is shaping the future of medical therapies. With his innovative patents and commitment to research, he continues to make significant contributions to the biopharmaceutical industry. His efforts in tumor immunotherapy and antibody display techniques demonstrate the profound impact that dedicated inventors can have on advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…